Testing effectiveness (Phase 2)Study completedNCT00132028
What this trial is testing
Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma
Who this might be right for
Adult Favorable Prognosis Hodgkin LymphomaAdult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin Lymphoma+5 more
National Cancer Institute (NCI) 27